Butibufen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H20O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JSS1TEM917, chemically known as butyric acid, 2-(4-isobutylphenyl)- but generally known as butibufen, which bears US NIH Compound Identifier 41643. European Medicines Agency schedules Butibufen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06015MIG. The term BUTIBUFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). BUTIBUFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule butibufen under HS 29163900 and SITC 51379. As of Q4 2014, BUTIBUFEN remains the US FDA Preferred Term for this commodity. Butibufen bears US NLM identifiers UMLS ID C0054255 and NCI Concept Code C73083. SMILES: OC(=O)C(C1CCC(CC(C)C)CC1)CC.